Agape ATP Corp (ATPC) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This summary covers the unaudited quarterly report (Form 10-Q) for Agape ATP Corp for the period ended June 30, 2024. The Company, incorporated in Nevada, operates primarily in the Health and Wellness industry in Malaysia, offering products (supplements, beauty, complementary therapies) and advisory services via network marketing. The Company is also diversifying into renewable energy through a new subsidiary, ATPC Green Energy Sdn. Bhd.
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | Value (USD) |
|---|---|
| Total Revenue | $631,682 |
| Gross Profit | $396,981 |
| Gross Margin | 62.8% |
| Net Loss | $(1,135,410) |
| Net Loss Attributable to Agape ATP Corp | $(1,152,407) |
| Loss Per Share (Basic & Diluted) | $(0.01) |
| Cash and Cash Equivalents | $3,160,984 |
| Total Assets | $4,268,401 |
| Total Liabilities | $1,019,850 |
| Accumulated Deficit | $(8,199,977) |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by 7.7% to $631,682 compared to $684,703 in the prior year period. This was driven by a 71.1% drop in network marketing revenue ($66,325 vs. $229,521), partially offset by a 24.2% increase in complementary health therapies revenue ($565,357 vs. $455,182).
- Expense Increase: Total operating expenses rose 24.7% to $1,574,105. General and Administrative (G&A) expenses increased significantly by 37.8% to $1,469,070, primarily due to director salaries, professional fees, and Nasdaq listing fees.
- Widening Loss: Net loss increased by 39.6% to $1,135,410, attributed to the revenue decline and higher operating costs.
- Cash Flow: Net cash used in operating activities was $1,656,000, a significant increase from $742,175 in the prior year, largely due to increased prepayments and deposits and higher operating losses.
Outlook, Risks, and Contingencies
- Internal Control Weaknesses: Management concluded that disclosure controls and internal controls over financial reporting were not effective as of June 30, 2024. Material weaknesses include insufficient accounting personnel and a lack of an internal audit function.
- Liquidity: While the Company holds over $3.1 million in cash and time deposits, it reported a working capital deficit of approximately $3.0 million. The Company has no credit facilities.
- Concentration Risk: Two vendors accounted for approximately 87.5% of total purchases in the first half of 2024. One sales distributor accounted for 19.8% of commission expenses.
- Foreign Exchange: The Company is exposed to exchange rate fluctuations between the Malaysian Ringgit, Hong Kong Dollar, and US Dollar, which impacts reported financial results.
- Strategic Shift: The Company is actively pursuing renewable energy initiatives through its new subsidiary, ATPC Green Energy, though this segment is in early stages.
Investor Verification Checklist
- Internal Controls: Verify the timeline and progress of remediation plans for the identified material weaknesses in financial reporting.
- Revenue Mix: Assess the sustainability of the shift from network marketing to complementary health therapies and the impact of limited product ranges on future growth.
- Cash Burn Rate: Monitor the rate of cash consumption given the significant operating cash outflow and lack of external credit facilities.
- Related Party Transactions: Review the volume and terms of transactions with related parties (e.g., CTA Nutriceuticals, TH3 Holdings) which constitute a significant portion of purchases and expenses.
- Valuation of Investments: Review the fair value and unrealized losses associated with marketable securities (Greenpro Capital Corp, DSwiss, SEATech).